Agilent Technologies (NYSE:A) Coverage Initiated by Analysts at Deutsche Bank Aktiengesellschaft

Research analysts at Deutsche Bank Aktiengesellschaft started coverage on shares of Agilent Technologies (NYSE:A) in a research report issued on Monday, Briefing.com reports. The brokerage set a “buy” rating and a $190.00 price target on the medical research company’s stock. Deutsche Bank Aktiengesellschaft‘s price objective would suggest a potential upside of 9.84% from the stock’s previous close.

A number of other equities analysts have also recently weighed in on A. Weiss Ratings raised Agilent Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Bank of America raised their target price on shares of Agilent Technologies from $180.00 to $190.00 in a report on Friday, October 9th. The Goldman Sachs Group lifted their target price on shares of Agilent Technologies from $175.00 to $185.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. Robert W. Baird lifted their target price on shares of Agilent Technologies from $180.00 to $195.00 and gave the stock an “outperform” rating in a research report on Thursday, October 8th. Finally, Rothschild & Co Redburn boosted their price target on shares of Agilent Technologies from $160.00 to $180.00 and gave the company a “buy” rating in a report on Thursday, August 27th. Eighteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $181.45.

Agilent Technologies Stock Performance

A opened at $172.98 on Monday. The firm has a market cap of $48.77 billion, a PE ratio of 34.05, a P/E/G ratio of 2.63 and a beta of 1.21. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. The business has a fifty day simple moving average of $161.48 and a 200-day simple moving average of $139.79. Agilent Technologies has a fifty-two week low of $108.35 and a fifty-two week high of $179.10.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. During the same period in the previous year, the firm earned $1.37 earnings per share. Agilent Technologies’s revenue for the quarter was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, equities analysts predict that Agilent Technologies will post 6.20 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Mikael Dolsten sold 634 shares of the stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the sale, the director directly owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. This represents a 11.41% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Institutional Investors Weigh In On Agilent Technologies

Institutional investors have recently bought and sold shares of the business. Bank of Nova Scotia purchased a new stake in Agilent Technologies in the 2nd quarter worth approximately $58,539,000. Dudley & Shanley Inc. boosted its stake in shares of Agilent Technologies by 25.9% during the 2nd quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock valued at $9,232,000 after buying an additional 14,300 shares during the period. BIP Wealth LLC purchased a new position in shares of Agilent Technologies during the 2nd quarter valued at $834,000. Sivia Capital Partners LLC purchased a new position in shares of Agilent Technologies during the 2nd quarter valued at $1,818,000. Finally, Capricorn Fund Managers Ltd purchased a new position in shares of Agilent Technologies during the 1st quarter valued at $8,161,000.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.